Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
~37 mi.
(Auburn,
New York,
+469 more cities)
Hematology Oncology Associates of Central New York-Auburn
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
~37 mi.
(Auburn,
New York,
+954 more cities)
Hematology Oncology Associates of Central New York-Auburn
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
~37 mi.
(Auburn,
New York,
+637 more cities)
Hematology Oncology Associates of Central New York-Auburn
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
~37 mi.
(Auburn,
New York,
+256 more cities)
Hematology Oncology Associates of Central New York-Auburn
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer